Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
Gut
Chou, Angela A; Froio, Danielle D; Nagrial, Adnan M AM; Parkin, Ashleigh A; Murphy, Kendelle J KJ; Chin, Venessa T VT; Wohl, Dalia D; Steinmann, Angela A; Stark, Rhys R; Drury, Alison A; Walters, Stacey N SN; Vennin, Claire C; Burgess, Andrew A; Pinese, Mark M; Chantrill, Lorraine A LA; Cowley, Mark J MJ; Molloy, Timothy J TJ; , ; Waddell, Nicola N; Johns, Amber A; Grimmond, Sean M SM; Chang, David K DK; Biankin, Andrew V AV; Sansom, Owen J OJ; Morton, Jennifer P JP; Grey, Shane T ST; Cox, Thomas R TR; Turchini, John J; Samra, Jaswinder J; Clarke, Stephen J SJ; Timpson, Paul P; Gill, Anthony J AJ; Pajic, Marina M
HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
Scientific Reports
Jäger, Daniela D; Barth, Thomas F E TFE; Brüderlein, Silke S; Scheuerle, Angelika A; Rinner, Beate B; von Witzleben, Adrian A; Lechel, André A; Meyer, Patrick P; Mayer-Steinacker, Regine R; Baer, Alexandra von AV; Schultheiss, Markus M; Wirtz, Christian R CR; Möller, Peter P; Mellert, Kevin K
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B
Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes.
Human Molecular Genetics
Taylor, Claire F CF; Platt, Fiona M FM; Hurst, Carolyn D CD; Thygesen, Helene H HH; Knowles, Margaret A MA